FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 10702-201 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerKVK-Tech, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209335
Dosage form / routeTABLET · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started20171222
Package count3

External sources

Source: openFDA. Public-domain (CC0).